Douglas J Swirsky's Net Worth

$38.7 Thousand

Estimate Recalculated Apr 15, 2024 03:12PM EST

Who is Douglas J Swirsky?

Douglas J Swirsky does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include POLYMEDIX, INC, Fibrocell Science, Inc., NeuroBo Pharmaceuticals, Inc., REXAHN PHARMACEUTICALS, INC., Cellectar Biosciences, Inc., GENVEC INC, PERNIX THERAPEUTICS HOLDINGS, INC., and MAXCYTE, INC..

SEC CIK

Douglas J Swirsky's CIK is 0001375884

Past Insider Trading and Trends

2011 was Douglas J Swirsky's most active year for acquiring shares with 15 total transactions. Douglas J Swirsky's most active month to acquire stocks was the month of December. 2019 was Douglas J Swirsky's most active year for disposing of shares, totalling 8 transactions. Douglas J Swirsky's most active month to dispose stocks was the month of November. 2017 saw Douglas J Swirsky paying a total of $140,000.00 for 115,000 shares, this is the most they've acquired in one year. In 2016 Douglas J Swirsky cashed out on 20,930 shares for a total of $150,486.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

POLYMEDIX, INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 26
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Sep 2
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

Fibrocell Science, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jul 19
Form 4
—
0
—
—
0
Mar 4
Form 3
—
0
—
—
0
No matching records found

NeuroBo Pharmaceuticals, Inc. (NRBO) Snapshot price: $4.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 1
Form 3
—
0
—
—
0
No matching records found

REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $2.46

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
50K
$0.63
$31,720.00
50K
Jan 29
Form 4
—
0
—
—
0
Nov 14
Form 4
—
0
—
—
0
Jan 2
Form 3
—
0
—
—
0
No matching records found

Cellectar Biosciences, Inc. (CLRB) Snapshot price: $3.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 24
Form 4
∞
25K
$1.04
$26,000.00
25K
Sep 14
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Oct 12
Form 4
—
0
—
—
0
May 31
Form 3
—
0
—
—
0
No matching records found